Evidence for Implementation: Management of TB in HIV and Pregnancy

Clinical standards for the diagnosis, treatment and prevention of TB infection

(2022) G. B. Migliori et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Stages of pregnancy and HIV affect diagnosis of tuberculosis infection and Mycobacterium tuberculosis (MTB)-induced immune response: Findings from PRACHITi, a cohort study in Pune, India

(2021) Ramesh Bhosale et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomics

(2021) Ahizechukwu C. Eke   Journal of Basic and Clinical Physiology and Pharmacology

Maternal and infant outcomes among pregnant women treated for multidrug/rifampicin-resistant tuberculosis in South Africa

(2020) Marian Loveday et al.   CLINICAL INFECTIOUS DISEASES

Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug–drug interaction randomized trial

(2020) Daniel Atwine et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

An interactive web-based dashboard to track COVID-19 in real time

(2020) Ensheng Dong et al.   LANCET INFECTIOUS DISEASES

The Bewildering Antitubercular Action of Pyrazinamide

(2020) Elise A. Lamont et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Safety of Antimicrobials During Pregnancy: A Systematic Review of Antimicrobials Considered for Treatment and Postexposure Prophylaxis of Plague

(2020) Patricia A Yu et al.   CLINICAL INFECTIOUS DISEASES

Tuberculosis clinical presentation and treatment outcomes in pregnancy: a prospective cohort study

(2020) Brittney J. van de Water et al.   BMC INFECTIOUS DISEASES

Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping

(2020) Kamunkhwala Gausi et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacologic Research in Pregnant Women — Time to Get It Right

(2019) Ahizechukwu C. Eke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Isoniazid Preventive Therapy and Pregnancy Outcomes In HIV-Infected Women in the Tshepiso Cohort

(2019) Nicole Salazar-Austin et al.   CLINICAL INFECTIOUS DISEASES

Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women

(2019) Amita Gupta et al.   NEW ENGLAND JOURNAL OF MEDICINE

Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV

(2019) Mahmoud Tareq Abdelwahab et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Predicting drug-drug interactions between rifampicin and long-acting cabotegravir and rilpivirine using PBPK modelling

(2018) Rajith K R Rajoli et al.   JOURNAL OF INFECTIOUS DISEASES

Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis

(2017) Els Van Kampenhout et al.   EUROPEAN RESPIRATORY JOURNAL

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis

(2016) Payam Nahid et al.   CLINICAL INFECTIOUS DISEASES

Pregnancy in patients with tuberculosis: a TBNET cross-sectional survey

(2016) Graham H. Bothamley et al.   BMC Pregnancy and Childbirth

Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South Africa

(2015) Paolo Denti et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis

(2015) P. Isaakidis et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Nutritional Supplementation Increases Rifampin Exposure among Tuberculosis Patients Coinfected with HIV

(2014) Kidola Jeremiah et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Lopinavir-Ritonavir or Nevirapine on Bedaquiline Exposures and Potential Implications for Patients with Tuberculosis-HIV Coinfection

(2014) Elin M. Svensson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Designing Drug Trials: Considerations for Pregnant Women

(2014) Jeanne S. Sheffield et al.   CLINICAL INFECTIOUS DISEASES

Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Updated Guidelines From the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America

(2014) H. Masur et al.   CLINICAL INFECTIOUS DISEASES

Tuberculosis in pregnancy: an estimate of the global burden of disease

(2014) Jordan Sugarman et al.   Lancet Global Health

Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis

(2013) Elin M. Svensson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients

(2013) Mathieu S. Bolhuis et al.   EUROPEAN RESPIRATORY JOURNAL

Clinical pharmacokinetics of antiretroviral drugs in older persons

(2013) John C Schoen et al.   Expert Opinion on Drug Metabolism & Toxicology

Dependence of Efavirenz- and Rifampicin-Isoniazid–Based Antituberculosis Treatment Drug-Drug Interaction on CYP2B6 and NAT2 Genetic Polymorphisms: ANRS 12154 Study in Cambodia

(2013) Julie Bertrand et al.   JOURNAL OF INFECTIOUS DISEASES

High Prevalence of Pulmonary Tuberculosis but Low Sensitivity of Symptom Screening among HIV-Infected Pregnant Women in South Africa

(2013) Christopher J. Hoffmann et al.   PLoS One

Tuberculosis in Pregnant and Postpartum Women: Epidemiology, Management, and Research Gaps

(2012) J. S. Mathad et al.   CLINICAL INFECTIOUS DISEASES

Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin

(2012) Kelly E. Dooley et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Outcomes of Multidrug-Resistant Tuberculosis Treatment with Early Initiation of Antiretroviral Therapy for HIV Co-Infected Patients in Lesotho

(2012) Hind Satti et al.   PLoS One

Prenatal exposure to anti tubercular drugs and postnatal effect on growth, development and cognitive ability in rats

(2012) Bharathi K.N. et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Caracterização da tuberculose multidroga resistente durante a gravidez, em Campinas, Estado de São Paulo, Brasil, no período de 1995 a 2007

(2012) Helenice Bosco de Oliveira et al.   Revista da Sociedade Brasileira de Medicina Tropical

Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience

(2011) A. D. Pranger et al.   EUROPEAN RESPIRATORY JOURNAL

Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy [Short communication]

(2011) P. Tabarsi et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Experience with rifabutin replacing rifampin in the treatment of tuberculosis

(2011) D.J. Horne et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Active Tuberculosis Case-Finding Among Pregnant Women Presenting to Antenatal Clinics in Soweto, South Africa

(2011) Celine R Gounder et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers

(2011) Kelly E. Dooley et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

(2011) Taraz Samandari et al.   LANCET

New Regimens to Prevent Tuberculosis in Adults with HIV Infection

(2011) Neil A. Martinson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiretroviral Program Associated with Reduction in Untreated Prevalent Tuberculosis in a South African Township

(2010) Keren Middelkoop et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pharmacokinetics of Darunavir/Ritonavir and Rifabutin Coadministered in HIV-Negative Healthy Volunteers

(2010) V. Sekar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Latent tuberculosis among pregnant mothers in a resource poor setting in Northern Tanzania: a cross-sectional study

(2010) Faheem G Sheriff et al.   BMC INFECTIOUS DISEASES

Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources

(2010) Stephen D Lawn et al.   LANCET INFECTIOUS DISEASES

Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

(2010) Salim S. Abdool Karim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort

(2009) Jonathan E Golub et al.   AIDS

Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection

(2009) R. Yost et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Tuberculosis in pregnancy in the UK

(2009) M Knight et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Pregnancy and tuberculosis: to assess tuberculosis cases in pregnancy in a developing region retrospectively and two case reports

(2008) Nadi Keskin et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS